Literature DB >> 18411194

Implementation of a comprehensive cancer plan. A health planning experience.

José Expósito Hernández1, Carmen Domínguez Nogueira, Carmen Escalera de Andrés.   

Abstract

Here we describe the working method used to implement an Integrated Cancer Health Plan in Andalusia (Spain) and to set out some of the lines of work for improving quality of care and health network planning. Four main initial considerations were made: (1) work must be centred on patients and respect for their autonomy; (2) cancer requires action at every healthcare level; (3) integration of expert professionals is to be encouraged; and (4) relevant information and data should be systematically used for planning. Two operative approaches were also established: structured participation and evidence-based healthcare. This methodology was used in various planning programmes, largely in relation to healthcare resources. In this article, as examples, we describe the development of two types of programmes: one for radiotherapy equipment and another for the management of lymphoedema in breast cancer patients. Analysis of results obtained against cancer is always controversial. It is necessary to review the healthcare structure used in terms of effectiveness and excellence. Comprehensive or integrated health plans are a useful model for a wide-ranging and multi-level approach to cancer. The structured and real participation of experts and an evidence- based healthcare strategy proved very useful in this public health planning experience.

Entities:  

Mesh:

Year:  2008        PMID: 18411194     DOI: 10.1007/s12094-008-0184-y

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  21 in total

1.  Palliative medicine and modern cancer care.

Authors:  S H Ahmedzai; D Walsh
Journal:  Semin Oncol       Date:  2000-02       Impact factor: 4.929

2.  European Code Against Cancer and scientific justification: third version (2003).

Authors:  P Boyle; P Autier; H Bartelink; J Baselga; P Boffetta; J Burn; H J G Burns; L Christensen; L Denis; M Dicato; V Diehl; R Doll; S Franceschi; C R Gillis; N Gray; L Griciute; A Hackshaw; M Kasler; M Kogevinas; S Kvinnsland; C La Vecchia; F Levi; J G McVie; P Maisonneuve; J M Martin-Moreno; J Newton Bishop; F Oleari; P Perrin; M Quinn; M Richards; U Ringborg; C Scully; E Siracka; H Storm; M Tubiana; T Tursz; U Veronesi; N Wald; W Weber; D G Zaridze; W Zatonski; H zur Hausen
Journal:  Ann Oncol       Date:  2003-07       Impact factor: 32.976

3.  Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection.

Authors:  Umberto Veronesi; Viviana Galimberti; Luigi Mariani; Giovanna Gatti; Giovanni Paganelli; Giuseppe Viale; Stefano Zurrida; Paolo Veronesi; Mattia Intra; Roberto Gennari; Anna Rita Vento; Alberto Luini; Marco Tullii; Guillermo Bassani; Nicole Rotmensz
Journal:  Eur J Cancer       Date:  2005-01       Impact factor: 9.162

4.  Disease management practices of health plans.

Authors:  W Pete Welch; Christopher Bergsten; Charles Cutler; Carmella Bocchino; Richard I Smith
Journal:  Am J Manag Care       Date:  2002-04       Impact factor: 2.229

Review 5.  Ensuring quality cancer care by the use of clinical practice guidelines and critical pathways.

Authors:  T J Smith; B E Hillner
Journal:  J Clin Oncol       Date:  2001-06-01       Impact factor: 44.544

6.  Referral rates and trends in radiotherapy as part of primary treatment of cancer in South Netherlands, 1988-2002.

Authors:  Ans Vulto; Marieke Louwman; Patrick Rodrigus; Jan Willem W Coebergh
Journal:  Radiother Oncol       Date:  2006-01-26       Impact factor: 6.280

7.  Risk of lymphoedema following the treatment of breast cancer.

Authors:  M W Kissin; G Querci della Rovere; D Easton; G Westbury
Journal:  Br J Surg       Date:  1986-07       Impact factor: 6.939

8.  Measuring progress against cancer in Europe: has the 15% decline targeted for 2000 come about?

Authors:  P Boyle; A d'Onofrio; P Maisonneuve; G Severi; C Robertson; M Tubiana; U Veronesi
Journal:  Ann Oncol       Date:  2003-08       Impact factor: 32.976

9.  Lung cancer. Practice organization.

Authors:  W Michael Alberts; Gerold Bepler; Todd Hazelton; John C Ruckdeschel; James H Williams
Journal:  Chest       Date:  2003-01       Impact factor: 9.410

10.  Characteristics of new referrals to twenty-seven lymphoedema treatment units.

Authors:  J Sitzia; M Woods; P Hine; A Williams; K Eaton; G Green
Journal:  Eur J Cancer Care (Engl)       Date:  1998-12       Impact factor: 2.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.